Factors affecting mortality in patients with healthcare-associated bloodstream infection due to Klebsiella pneumoniae
The Journal of Infection in Developing Countries · 2025
DOI: 10.3855/jidc.20442 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, 2025. Verfasst von Eyüp Arslan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Clinical Microbiology, Sancaktepe Şehit Prof. Dr. İlhan Varank Training and Research Hospital, Istanbul, Türkiy…. Hauptthemen laut MEDLINE: Klebsiella Infections, Klebsiella pneumoniae, Cross Infection, Bacteremia. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Klebsiella pneumoniae is a common causative agent of hospital-acquired (HA) bloodstream infections (BSI) in intensive care units (ICU). This study aimed to investigate mortality rates and the factors affecting mortality in BSI due to K. pneumoniae acquired in the ICU. Methodology: This retrospective study included adult patients hospitalized in the ICU between January 2021 and December 2022 who developed HA BSI due to K. pneumoniae. The association between clinical characteristics, invasive and medical treatment practices before bacteremia, and 15-day and 30-day mortality was investigated.
Results
A total of 232 patients (median age 68.0 years) were included. All-cause mortality rates on days 15 and 30 were 56.0% and 72.8%, respectively. The proportion of patients infected with carbapenem-resistant K. pneumoniae was 77.6%. Logistic regression analysis revealed significant associations between systemic corticosteroid use (OR: 2.38; p = 0.014), high qPitt score (OR: 1.32; p = 0.046), and presence of immunosuppression (OR: 2.70; p = 0.020); and 15-day mortality. Significant associations were found between systemic corticosteroid use (OR: 3.69; p = 0.002), high qPitt score (OR: 1.44; p = 0.043) and presence of immunosuppression (OR: 6.61; p = 0.004); and 30-day mortality.
Conclusions
Corticosteroid treatment before the development of bacteremia in ICU patients may contribute to mortality in BSI due to K. pneumoniae. Therefore, corticosteroids should be used with caution despite their benefit in the treatment of acute respiratory distress syndrome. High qPitt scores and the presence of immunosuppression may be used as predictors of mortality in HA BSI due to K. pneumoniae.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases and Clinical Microbiology, Sancaktepe Şehit Prof. Dr. İlhan Varank Training and Research Hospital, Istanbul, Türkiye.
- Department of Anesthesiology and Reanimation, Sancaktepe Şehit Prof. Dr. İlhan Varank Training and Research Hospital, Istanbul, Türkiye.
- Department of Biostatistics and Medical Informatics, Istanbul Medeniyet University Faculty of Medicine, Istanbul, Türkiye.
Zitieren
APA
Arslan, E., Çaydaşı, Ö., Şabablı Çetin, A., Yılmaz Karadağ, F., Büber, A. A., Adıyeke, E., Ankaralı, H., & Öztürk Engin, D. (2025). Factors affecting mortality in patients with healthcare-associated bloodstream infection due to Klebsiella pneumoniae. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.20442
Vancouver
Arslan E, Çaydaşı Ö, Şabablı Çetin A, Yılmaz Karadağ F, Büber AA, Adıyeke E, et al. Factors affecting mortality in patients with healthcare-associated bloodstream infection due to Klebsiella pneumoniae. The Journal of Infection in Developing Countries. 2025. doi:10.3855/jidc.20442
BibTeX
@article{Arslan2025,
author = {Arslan, Eyüp and Çaydaşı, Özge and Şabablı Çetin, Ayşe and Yılmaz Karadağ, Fatma and Büber, Aslıhan A and Adıyeke, Esra and Ankaralı, Handan and Öztürk Engin, Derya},
title = {Factors affecting mortality in patients with healthcare-associated bloodstream infection due to Klebsiella pneumoniae},
journal = {The Journal of Infection in Developing Countries},
year = {2025},
doi = {10.3855/jidc.20442}
}
EUVIMED